#FNAIT#AwarenessDay please watch and share!!! If you have been diagnosed with or suspect you may have fnait contact @naitbabies
https://t.co/5jod4zVHSY
🚨 Today, Rallybio announced the initiation of the Phase 2 clinical trial investigating RLYB212 in pregnant women at higher risk for HPA-1a alloimmunization and fetal and neonatal alloimmune thrombocytopenia (FNAIT).
FNAIT is officially on notice 📢 today, as we're announcing the approval of our lead program, RLYB212, to move into Phase 2 trials in pregnant women at higher risk of alloimmunization and FNAIT (fetal and neonatal alloimmune thrombocytopenia): https://t.co/VmKoEubBps
#RDD This little girl has complex #disabilities due to #FNAIT she is blind has epilepsy, a shunt in her head, cerebral palsy, fed via a gastronomy tube and other disabilities which have required major surgery. https://t.co/5uBqwRGb1B
Our #NAIT Babies are fighters ❤️
There are 300 million people worldwide living w/ a #raredisease. DYK: #FNAIT is a rare disease that occurs when there is a mismatch between the mother’s platelets & those of the baby, resulting in the destruction of platelets in the fetus or infant.
#RareDiseaseDay
Plasma donation is similar to blood donation and takes about 35 minutes. Plasma is part of the blood and is used to make medicines such as immunoglobulin which is used to treat more than 50 diseases including #FNAIT
November is #PrematurityAwarenessMonth. It's time to rally around the cause of #maternalhealth and infant health, particularly when it comes to preterm births. For us, it's also a reminder of why we're so dedicated to maternal and prenatal health. #FNAIT
How can you help babies during #PrematurityAwarenessMonth? By donating platelets! https://t.co/jpSfpiwrK9 Many premature babies need platelet transfusions to thrive. And, because platelets only have a shelf life of 5-7 days, there’s always a need.
Special thanks to @soniasodha for being the #GivingType and donating plasma recently at our Twickenham Donor Centre. 💙
Immunoglobulin, the medicine made from plasma, is used to treat more than 50 rare diseases and disorders.
Register interest ➡️ https://t.co/O9dzp0Qn5d
Today we announced proof-of-concept results and development updates for our lead product candidate for the prevention of Fetal and Neonatal Alloimmune Thrombocytopena (#FNAIT).
Learn more: https://t.co/GuO7Ol3Lfr
We’re @isth#ISTH2023- check out today’s oral presentation given by Christof Geisen, M.D. sharing results from our Phase 1b proof-of-concept study in Fetal and neonatal alloimmune thrombocytopenia (#FNAIT) at 1:00pm ET in Room 710A. #RareDisease#Rallybio
@romankemp@naitbabies the only charity in the world supporting families affected by Fetal Neonatal Alloimmune thrombocytopenia which affects the fetus and newborn but not screened for in pregnancy.
Run by volunteers